Exploratory/Developmental Program for Translational Research in Muscular Dystrophy (R21)
The summary for the Exploratory/Developmental Program for Translational Research in Muscular Dystrophy (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Exploratory/Developmental Program for Translational Research in Muscular Dystrophy (R21): The National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Institute of Child Health and Human Development (NICHD) solicit applications for translational research projects in muscular dystrophy. Several emerging pathways to treatment of muscular dystrophy show promise, ranging from palliative therapies that can markedly delay onset or progression of the disease to genetic or stem cell approaches that may reverse or eliminate the condition. The objective of this initiative is to encourage the pursuit of a broad range of translational research strategies for therapeutic development in muscular dystrophy. This Funding Opportunity Announcement (FOA) solicits exploratory/developmental applications that will provide the leads, tools, and resources needed for a subsequent therapy development project. Applications are encouraged for translational research exploratory/developmental projects for any one or more of the muscular dystrophies.
Federal Grant Title: | Exploratory/Developmental Program for Translational Research in Muscular Dystrophy (R21) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-06-203 |
Type of Funding: | Grant |
CFDA Numbers: | 93.84693.853 |
CFDA Descriptions: | Arthritis, Musculoskeletal and Skin Diseases Research 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Sep 02, 2007 Multiple Receipt Dates - See Link to |
Posted Date: | Mar 07, 2006 |
Creation Date: | May 23, 2007 |
Archive Date: | Oct 08, 2008 |
Total Program Funding: | $500,000 |
Maximum Federal Grant Award: | $200,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | 93.865 -- Child Health and Human Development Extramural Research |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal organizations (other than Federally recognized tribal governments) County governments Private institutions of higher education Public housing authorities/Indian housing authorities Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Special district governments For profit organizations other than small businesses
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster